+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

STD Diagnostics Market Size, Share & Trends Analysis Report by Application (HIV Testing, HSV Testing, Chlamydia Testing), Product, Technology, Location of Testing, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 156 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 5846796
Description Jump to:
The STD Diagnostics Market was valued at USD 10.63 billion in 2024, and is projected to reach USD 16.08 billion by 2030, rising at a CAGR of 7.10%. The increasing disease burden of Sexually Transmitted Disease (STD) and efforts by government & non-profit organizations to increase awareness and encourage regular screenings among the younger population are the key factors augmenting the market growth. According to WHO data, around 374 million new cases of syphilis, gonorrhea, chlamydia, and trichomoniasis are recorded every year globally.

Development and commercialization of advanced products, such as next-generation HIV testing kits and multiplex PCR products, enable physicians to timely diagnose & distinguish a range of STIs and provide appropriate treatment. Seegene, Inc., a South Korea-based diagnostic company, provides a wide portfolio of Allplex, Anyplex, and Seeplex products that detect various causative agents. For instance, Allplex STI/BV Panel Assay can distinguish 28 causative agents in a single test. In April 2022, Seegene, Inc. announced the development of Allplex HPV HR Detection.

Allplex HPV HR Detection is the world’s first commercialized ‘3 Ct’ PCR assay. Seegene is focusing to apply this technology to its entire product chain, including STI, Urinary Tract Infection (UTI), and Respiratory Virus (RV) assays. This strategic technological advancement is expected to provide an additional advantage to the company that can help increase its share in the Sexually Transmitted Disease (STD) diagnostics industry.

The HIV National Strategic Plan is a roadmap for eliminating the human immunodeficiency virus pandemic in the U.S. by 2030. The HIV Plan, which will run from 2021 to 2025, is the country's third five-year national HIV plan in a row, with a 10-year goal of halving new human immunodeficiency virus infections by 90% by 2030. Furthermore, the Viral Hepatitis National Strategic Plan focuses on hepatitis B and C, which are sexually transmitted. In January 2021, the US Department of Health and Human Services (HHS) released a nationwide strategy to address the preventable, substantial public health threats posed by viral hepatitis in the United States. The government's beneficial actions create a favorable atmosphere for the expansion of the STD diagnostics industry.

Companies are engaging in strategic initiatives that aid in the development of new products, and regulatory approvals as well as enhance their STD diagnostics product portfolio. For instance, in August 2020, DiaSorin, Inc. received 510 (k) approval from U.S. FDA for introducing LIAISON XL MUREX anti-HBe. It is used for the diagnosis of HBV infection. This immunoassay product works on the principle of chemiluminescence.

STD Diagnostics Market Report Highlights

  • The consumables segment dominated the market in 2024 with a revenue share of 70.01% and is anticipated to grow at the fastest CAGR over the forecast period owing to high testing rates for the diagnosis of STDs and the commercialization of several assays
  • Based on technology, the molecular diagnostics segment is estimated to grow at the fastest CAGR during the forecast period owing to the increasing use of high-throughput PCR technology and the recommendation of NAAT tests for HIV testing. The development of multiplex PCR tests for the simultaneous detection of multiple pathogens is also expected to contribute to the STD diagnostics industry's growth
  • Based on application, the HIV testing segment is expected to dominate the STD diagnostics industry in 2024, due to factors such as the high incidence rate of the disease, increasing product approvals for molecular tests, and favorable government initiatives
  • Asia-Pacific region is anticipated to experience the fastest growth over the forecast period due to an increase in testing rates for STDS, a rise in disposable income, and high disease prevalence of STD in developing countries

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. STD Diagnostics Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. STD Diagnostics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. STD Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. STD Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Million)
4.3. Instruments and Services
4.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4. Consumables
4.4.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Software
4.5.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. STD Diagnostics Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. STD Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Million)
5.3. CT/NG testing
5.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4. Syphilis testing
5.4.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4.2. PCR testing
5.4.2.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4.3. Non-PCR testing
5.4.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Gonorrhea testing
5.5.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.6. HSV testing
5.6.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.6.2. PCR testing
5.6.2.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.6.3. Non-PCR testing
5.6.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.7. HPV testing
5.7.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.8. HIV testing
5.8.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.9. Ureaplasma & Mycoplasma testing
5.9.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.10. Trichomonas
5.10.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.11. VZV testing
5.11.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.11.2. PCR testing
5.11.2.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.11.3. Non-PCR testing
5.11.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. STD Diagnostics Market: Technology Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. STD Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Million)
6.3. Immunoassay
6.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.4. Molecular Diagnostics
6.4.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Other
6.5.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. STD Diagnostics Market: Location of Testing Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. STD Diagnostics Market: Location of Testing Movement Analysis, 2024 & 2030 (USD Million)
7.3. Commercial/Private labs
7.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.4. Public Health Labs
7.4.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. STD Diagnostics Market: Regional Estimates & Trend Analysis
8.1. STD Diagnostics Market Share, By Region, 2024 & 2030, USD Million
8.2. North America
8.2.1. North America STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3. Europe
8.3.1. Europe STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.2. UK
8.3.2.1. UK STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.4. France
8.3.4.1. France STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.2. Japan
8.4.2.1. Japan STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.3. China
8.4.3.1. China STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.4. India
8.4.4.1. India STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.5. Australia
8.4.5.1. Australia STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.6. South Korea
8.4.6.1. South Korea STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Thailand STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5. Latin America
8.5.1. Latin America STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. South Africa STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.4. UAE
8.6.4.1. UAE STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait STD Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. BD
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. F. Hoffmann-La Roche Ltd
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. Hologic Inc.
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. Abbott
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Cepheid (Danaher)
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Qiagen
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. OraSure Technologies, Inc.
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Bio-Rad Laboratories, Inc.
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. bioMérieux SA
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. Thermo Fisher Scientific, Inc.
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives
9.4.11. Seegene Inc.
9.4.11.1. Participant’s Overview
9.4.11.2. Financial Performance
9.4.11.3. Product Benchmarking
9.4.11.4. Recent Developments/ Strategic Initiatives
9.4.12. DiaSorin S.p.A
9.4.12.1. Participant’s Overview
9.4.12.2. Financial Performance
9.4.12.3. Product Benchmarking
9.4.12.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global STD diagnostics market, by region, 2018-2030 (USD Million)
Table 3 Global STD diagnostics market, by product, 2018-2030 (USD Million)
Table 4 Global STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 5 Global STD diagnostics market, by application, 2018-2030 (USD Million)
Table 6 Global STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 7 North America STD diagnostics market, by country, 2018-2030 (USD Million)
Table 8 North America STD diagnostics market, by product, 2018-2030 (USD Million)
Table 9 North America STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 10 North America STD diagnostics market, by application, 2018-2030 (USD Million)
Table 11 North America STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 12 U.S. STD diagnostics market, by product, 2018-2030 (USD Million)
Table 13 U.S. STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 14 U.S. STD diagnostics market, by application, 2018-2030 (USD Million)
Table 15 U.S. STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 16 Canada STD diagnostics market, by product, 2018-2030 (USD Million)
Table 17 Canada STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 18 Canada STD diagnostics market, by application, 2018-2030 (USD Million)
Table 19 Canada STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 20 Mexico STD diagnostics market, by product, 2018-2030 (USD Million)
Table 21 Mexico STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 22 Mexico STD diagnostics market, by application, 2018-2030 (USD Million)
Table 23 Mexico STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 24 Europe STD diagnostics market, by country, 2018-2030 (USD Million)
Table 25 Europe STD diagnostics market, by product, 2018-2030 (USD Million)
Table 26 Europe STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 27 Europe STD diagnostics market, by application, 2018-2030 (USD Million)
Table 28 Europe STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 29 UK STD diagnostics market, by product, 2018-2030 (USD Million)
Table 30 UK STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 31 UK STD diagnostics market, by application, 2018-2030 (USD Million)
Table 32 UK STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 33 Germany STD diagnostics market, by product, 2018-2030 (USD Million)
Table 34 Germany STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 35 Germany STD diagnostics market, by application, 2018-2030 (USD Million)
Table 36 Germany STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 37 France STD diagnostics market, by product, 2018-2030 (USD Million)
Table 38 France STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 39 France STD diagnostics market, by application, 2018-2030 (USD Million)
Table 40 France STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 41 Italy STD diagnostics market, by product, 2018-2030 (USD Million)
Table 42 Italy STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 43 Italy STD diagnostics market, by application, 2018-2030 (USD Million)
Table 44 Italy STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 45 Spain STD diagnostics market, by product, 2018-2030 (USD Million)
Table 46 Spain STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 47 Spain STD diagnostics market, by application, 2018-2030 (USD Million)
Table 48 Spain STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 49 Denmark STD diagnostics market, by product, 2018-2030 (USD Million)
Table 50 Denmark STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 51 Denmark STD diagnostics market, by application, 2018-2030 (USD Million)
Table 52 Denmark STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 53 Sweden STD diagnostics market, by product, 2018-2030 (USD Million)
Table 54 Sweden STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 55 Sweden STD diagnostics market, by application, 2018-2030 (USD Million)
Table 56 Sweden STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 57 Norway STD diagnostics market, by product, 2018-2030 (USD Million)
Table 58 Norway STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 59 Norway STD diagnostics market, by application, 2018-2030 (USD Million)
Table 60 Norway STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 61 Asia Pacific STD diagnostics market, by country, 2018-2030 (USD Million)
Table 62 Asia Pacific STD diagnostics market, by product, 2018-2030 (USD Million)
Table 63 Asia Pacific STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 64 Asia Pacific STD diagnostics market, by application, 2018-2030 (USD Million)
Table 65 Asia Pacific STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 66 Japan STD diagnostics market, by product, 2018-2030 (USD Million)
Table 67 Japan STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 68 Japan STD diagnostics market, by application, 2018-2030 (USD Million)
Table 69 Japan STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 70 China STD diagnostics market, by product, 2018-2030 (USD Million)
Table 71 China STD diagnostics market, by application, 2018-2030 (USD Million)
Table 72 China STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 73 China STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 74 India STD diagnostics market, by product, 2018-2030 (USD Million)
Table 75 India STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 76 India STD diagnostics market, by application, 2018-2030 (USD Million)
Table 77 India STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 78 Australia STD diagnostics market, by product, 2018-2030 (USD Million)
Table 79 Australia STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 80 Australia STD diagnostics market, by application, 2018-2030 (USD Million)
Table 81 Australia STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 82 South Korea STD diagnostics market, by product, 2018-2030 (USD Million)
Table 83 South Korea STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 84 South Korea STD diagnostics market, by application, 2018-2030 (USD Million)
Table 85 South Korea STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 86 Thailand STD diagnostics market, by product, 2018-2030 (USD Million)
Table 87 Thailand STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 88 Thailand STD diagnostics market, by application, 2018-2030 (USD Million)
Table 89 Thailand STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 90 Latin America STD diagnostics market, by country, 2018-2030 (USD Million)
Table 91 Latin America STD diagnostics market, by product, 2018-2030 (USD Million)
Table 92 Latin America STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 93 Latin America STD diagnostics market, by application, 2018-2030 (USD Million)
Table 94 Latin America STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 95 Brazil STD diagnostics market, by product, 2018-2030 (USD Million)
Table 96 Brazil STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 97 Brazil STD diagnostics market, by application, 2018-2030 (USD Million)
Table 98 Brazil STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 99 Argentina STD diagnostics market, by product, 2018-2030 (USD Million)
Table 100 Argentina STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 101 Argentina STD diagnostics market, by application, 2018-2030 (USD Million)
Table 102 Argentina STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 103 MEA STD diagnostics market, by country, 2018-2030 (USD Million)
Table 104 MEA STD diagnostics market, by product, 2018-2030 (USD Million)
Table 105 MEA STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 106 MEA STD diagnostics market, by application, 2018-2030 (USD Million)
Table 107 MEA STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 108 South Africa STD diagnostics market, by product, 2018-2030 (USD Million)
Table 109 South Africa STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 110 South Africa STD diagnostics market, by application, 2018-2030 (USD Million)
Table 111 South Africa STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 112 Saudi Arabia STD diagnostics market, by product, 2018-2030 (USD Million)
Table 113 Saudi Arabia STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 114 Saudi Arabia STD diagnostics market, by application, 2018-2030 (USD Million)
Table 115 Saudi Arabia STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 116 UAE STD diagnostics market, by product, 2018-2030 (USD Million)
Table 117 UAE STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 118 UAE STD diagnostics market, by application, 2018-2030 (USD Million)
Table 119 UAE STD diagnostics market, by location of testing, 2018-2030 (USD Million)
Table 120 Kuwait STD diagnostics market, by product, 2018-2030 (USD Million)
Table 121 Kuwait STD diagnostics market, by technology, 2018-2030 (USD Million)
Table 122 Kuwait STD diagnostics market, by application, 2018-2030 (USD Million)
Table 123 Kuwait STD diagnostics market, by location of testing, 2018-2030 (USD Million)
List of Figures
Figure 1 STD Diagnostics Market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Market outlook (2023)
Figure 10 Penetration and growth prospect mapping
Figure 11 User perspective analysis
Figure 12 STD Diagnostics Market driver impact
Figure 13 Prevalence of STIs by WHO regions (in 2023)
Figure 14 STD Diagnostics Market restraint impact
Figure 15 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
Figure 16 Porter’s Five Forces Analysis
Figure 17 STD diagnostics product outlook: Key takeaways
Figure 18 STD Diagnostics Market: Product movement analysis
Figure 19 Instruments and Services market, 2018-2030 (USD Million)
Figure 20 Consumables market, 2018-2030 (USD Million)
Figure 21 Software market, 2018-2030 (USD Million)
Figure 22 STD diagnostics application outlook: Key takeaways
Figure 23 STD Diagnostics Market: Application movement analysis
Figure 24 CT/NG testing market, 2018-2030 (USD Million)
Figure 25 Prevalence (%) of syphilis by WHO regions
Figure 26 Syphilis testing market, 2018-2030 (USD Million)
Figure 27 Syphilis PCR testing market, 2018-2030 (USD Million)
Figure 28 Syphilis non-PCR testing market, 2018-2030 (USD Million)
Figure 29 HSV testing market, 2018-2030 (USD Million)
Figure 30 Herpes Simplex Virus PCR testing market, 2018-2030 (USD Million)
Figure 31 Herpes Simplex Virus non-PCR testing market, 2018-2030 (USD Million)
Figure 32 HPV testing market, 2018-2030 (USD Million)
Figure 33 Prevalence (%) of HIV by WHO regions
Figure 34 HIV testing market, 2018-2030 (USD Million)
Figure 35 Ureaplasma & mycoplasma testing market, 2018-2030 (USD Million)
Figure 36 Trichomonas testing market, 2018-2030 (USD Million)
Figure 37 VZV testing market, 2018-2030 (USD Million)
Figure 38 VZV PCR testing market, 2018-2030 (USD Million)
Figure 39 VZV non-PCR testing market, 2018-2030 (USD Million)
Figure 40 Other testing market, 2018-2030 (USD Million)
Figure 41 STD diagnostics technology outlook: Key takeaways
Figure 42 STD Diagnostics Market: Technology movement analysis
Figure 43 Molecular Diagnostics market, 2018-2030 (USD Million)
Figure 44 Immunoassay market, 2018-2030 (USD Million)
Figure 45 Others market, 2018-2030 (USD Million)
Figure 46 STD diagnostics location of testing outlook: Key takeaways
Figure 47 STD Diagnostics Market: Location of testing movement analysis
Figure 48 Laboratory testing market, 2018-2030 (USD Million)
Figure 49 Commercial/private labs market, 2018-2030 (USD Million)
Figure 50 Public health labs market, 2018-2030 (USD Million)
Figure 51 Point of care testing market, 2018-2030 (USD Million)
Figure 52 Regional outlook, 2023 & 2030
Figure 53 Regional marketplace: Key takeaways
Figure 54 North America SWOT
Figure 55 North America STD Diagnostics Market, 2018-2030 (USD Million)
Figure 56 U.S. Country Dynamics
Figure 57 U.S. Target Disease Prevalence
Figure 58 U.S. STD Diagnostics Market, 2018-2030 (USD Million)
Figure 59 Canada Country Dynamics
Figure 60 Canada Target Disease Prevalence
Figure 61 Canada STD Diagnostics Market, 2018-2030 (USD Million)
Figure 61 Mexico Target Disease Prevalence
Figure 62 Mexico STD Diagnostics Market, 2018-2030 (USD Million)
Figure 62 Europe SWOT
Figure 63 Europe STD Diagnostics Market, 2018-2030 (USD Million)
Figure 64 UK Country Dynamics
Figure 65 UK Target Disease Prevalence
Figure 66 UK STD Diagnostics Market, 2018-2030 (USD Million)
Figure 67 Germany Country Dynamics
Figure 68 Germany Target Disease Prevalence
Figure 69 Germany STD Diagnostics Market, 2018-2030 (USD Million)
Figure 70 France Country Dynamics
Figure 71 France Target Disease Prevalence
Figure 72 France STD Diagnostics Market, 2018-2030 (USD Million)
Figure 73 Spain Country Dynamics
Figure 74 Spain Target Disease Prevalence
Figure 75 Spain STD Diagnostics Market, 2018-2030 (USD Million)
Figure 76 Italy Country Dynamics
Figure 77 Italy Target Disease Prevalence
Figure 78 Italy STD Diagnostics Market, 2018-2030 (USD Million)
Figure 79 Denmark Country Dynamics
Figure 80 Denmark Target Disease Prevalence
Figure 81 Denmark STD Diagnostics Market, 2018-2030 (USD Million)
Figure 82 Sweden Country Dynamics
Figure 83 Sweden Target Disease Prevalence
Figure 84 Sweden STD Diagnostics Market, 2018-2030 (USD Million)
Figure 85 Denmark Country Dynamics
Figure 86 Denmark Target Disease Prevalence
Figure 87 Denmark STD Diagnostics Market, 2018-2030 (USD Million)
Figure 88 Asia Pacific SWOT
Figure 89 Asia Pacific STD Diagnostics Market, 2018-2030 (USD Million)
Figure 90 Japan Country Dynamics
Figure 91 Japan Target Disease Prevalence
Figure 92 Japan STD Diagnostics Market, 2018-2030 (USD Million)
Figure 93 China Country Dynamics
Figure 94 China Target Disease Prevalence
Figure 95 China STD Diagnostics Market, 2018-2030 (USD Million)
Figure 96 India Country Dynamics
Figure 97 India Target Disease Prevalence
Figure 98 India STD Diagnostics Market, 2018-2030 (USD Million)
Figure 99 Australia Country Dynamics
Figure 100 Australia Target Disease Prevalence
Figure 101 Australia STD Diagnostics Market, 2018-2030 (USD Million)
Figure 102 South Korea Country Dynamics
Figure 103 South Korea Target Disease Prevalence
Figure 104 South Korea STD Diagnostics Market, 2018-2030 (USD Million)
Figure 105 Thailand Country Dynamics
Figure 106 Thailand Target Disease Prevalence
Figure 107 Thailand STD Diagnostics Market, 2018-2030 (USD Million)
Figure 108 Latin America SWOT
Figure 109 Latin America STD Diagnostics Market, 2018-2030 (USD Million)
Figure 110 Brazil Country Dynamics
Figure 111 Brazil Target Disease Prevalence
Figure 112 Brazil STD Diagnostics Market, 2018-2030 (USD Million)
Figure 113 Mexico Country Dynamics
Figure 116 Argentina Country Dynamics
Figure 117 Argentina Target Disease Prevalence
Figure 118 Argentina STD Diagnostics Market, 2018-2030 (USD Million)
Figure 119 Middle East & Africa SWOT
Figure 120 Middle East & Africa STD Diagnostics Market, 2018-2030 (USD Million)
Figure 121 South Africa Country Dynamics
Figure 122 South Africa Target Disease Prevalence
Figure 123 South Africa STD Diagnostics Market, 2018-2030 (USD Million)
Figure 124 Saudi Arabia Country Dynamics
Figure 125 Saudi Arabia Target Disease Prevalence
Figure 126 Saudi Arabia STD Diagnostics Market, 2018-2030 (USD Million)
Figure 127 UAE Country Dynamics
Figure 128 UAE Target Disease Prevalence
Figure 129 UAE STD Diagnostics Market, 2018-2030 (USD Million)
Figure 130 Kuwait Country Dynamics
Figure 131 Kuwait Target Disease Prevalence
Figure 132 Kuwait STD Diagnostics Market, 2018-2030 (USD Million)
Figure 133 Heat map analysis
Figure 134 Company market share analysis (2024)
Figure 135 Company market position analysis (2024)
Figure 136 Company market position analysis (2024)
Figure 137 Market differentiators
Figure 138 Regional Network Map

Companies Mentioned

The major companies featured in this STD Diagnostics market report include:
  • BD
  • F. Hoffmann-La Roche Ltd
  • Hologic Inc.
  • Abbott
  • Cepheid (Danaher)
  • Qiagen
  • OraSure Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Thermo Fisher Scientific, Inc.
  • Seegene Inc.
  • DiaSorin S.p.A

Table Information

Report AttributeDetails
No. of Pages156
PublishedMay 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 10.63 Billion
Forecasted Market Value ( USD ) by 2030 $ 16.08 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

STD Testing Market by Test Type, End User, Product, Technology, Distribution Channel, Disease Type, Sample Type - Global Forecast to 2030 - Product Image

STD Testing Market by Test Type, End User, Product, Technology, Distribution Channel, Disease Type, Sample Type - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Sexually Transmitted Disease Diagnostics Market by Diagnostic Test Types, Pathogen Types, End-User Types, Sample Types, Technology Types, Product Types - Global Forecast to 2030 - Product Image

Sexually Transmitted Disease Diagnostics Market by Diagnostic Test Types, Pathogen Types, End-User Types, Sample Types, Technology Types, Product Types - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
STD Self-Testing Market Size, Share & Trends Analysis Report by Application (CT/NG Testing, Syphilis Testing, HIV Testing), and Region (North America, Asia-Pacific, Europe, Latin America, MEA) with Growth Forecasts, 2025-2030 - Product Image

STD Self-Testing Market Size, Share & Trends Analysis Report by Application (CT/NG Testing, Syphilis Testing, HIV Testing), and Region (North America, Asia-Pacific, Europe, Latin America, MEA) with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Molecular Diagnostics For STD Market Size, Share & Trends Analysis Report By Product (Instruments & Services, Consumables), By Application (Chlamydia Testing, Syphilis Testing), By Technology (Laboratory Testing), By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Molecular Diagnostics For STD Market Size, Share & Trends Analysis Report By Product (Instruments & Services, Consumables), By Application (Chlamydia Testing, Syphilis Testing), By Technology (Laboratory Testing), By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 100 Pages
  • Global
From
Sexually Transmitted Disease Diagnostics Market Report by Type, Device Type, End User, and Region 2025-2033 - Product Image

Sexually Transmitted Disease Diagnostics Market Report by Type, Device Type, End User, and Region 2025-2033

  • Report
  • 143 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.